<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on 4 September 2026 at 22:52 by All in One SEO v5.0.1.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://kivetonpharmacy.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Kiveton Pharmacy</title>
		<link><![CDATA[https://kivetonpharmacy.com]]></link>
		<description><![CDATA[Kiveton Pharmacy]]></description>
		<lastBuildDate><![CDATA[Wed, 26 Aug 2026 13:01:32 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://kivetonpharmacy.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://kivetonpharmacy.com/cobalt-chrome-modular-neck-hip-replacements-risk-of-metal-wear-effects-and-revision-surgery-dsi-2026-010/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/cobalt-chrome-modular-neck-hip-replacements-risk-of-metal-wear-effects-and-revision-surgery-dsi-2026-010/]]></link>
			<title>Cobalt-chrome modular neck hip replacements: risk of metal-wear effects and revision surgery (DSI/2026/010)</title>
			<pubDate><![CDATA[Wed, 26 Aug 2026 13:01:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/filters-should-be-used-during-the-administration-of-parenteral-nutrition-for-patients-in-all-care-settings-dsi-2026-011/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/filters-should-be-used-during-the-administration-of-parenteral-nutrition-for-patients-in-all-care-settings-dsi-2026-011/]]></link>
			<title>Filters should be used during the administration of Parenteral Nutrition for patients in all care settings DSI/2026/011</title>
			<pubDate><![CDATA[Wed, 02 Sep 2026 09:59:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-20-to-24-july-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-20-to-24-july-2026/]]></link>
			<title>Field Safety Notices: 20 to 24 July 2026</title>
			<pubDate><![CDATA[Tue, 28 Jul 2026 10:57:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-august-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-august-2026/]]></link>
			<title>MHRA Safety Roundup: August 2026</title>
			<pubDate><![CDATA[Tue, 25 Aug 2026 13:02:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-zentiva-pharma-uk-limited-fingolimod-zentiva-0-5-mg-capsules-el26a-37/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-zentiva-pharma-uk-limited-fingolimod-zentiva-0-5-mg-capsules-el26a-37/]]></link>
			<title>Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37</title>
			<pubDate><![CDATA[Thu, 20 Aug 2026 13:21:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/ngpod-ph-testing-device-quarantine-and-dispose-of-all-devices-dsi-2026-009/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/ngpod-ph-testing-device-quarantine-and-dispose-of-all-devices-dsi-2026-009/]]></link>
			<title>NGPod pH testing device: quarantine and dispose of all devices (DSI/2026/009)</title>
			<pubDate><![CDATA[Mon, 24 Aug 2026 13:16:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-17-to-21-august-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-17-to-21-august-2026/]]></link>
			<title>Field Safety Notices: 17 to 21 August 2026</title>
			<pubDate><![CDATA[Mon, 24 Aug 2026 12:32:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-13-to-17-july-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-13-to-17-july-2026/]]></link>
			<title>Field Safety Notices: 13 to 17 July 2026</title>
			<pubDate><![CDATA[Tue, 21 Jul 2026 08:16:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/all-rectal-catheters-gas-and-colic-relievers-do-not-use-in-infants-including-for-the-treatment-of-colic-gas-related-discomfort-or-constipation-dsi-2026-008/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/all-rectal-catheters-gas-and-colic-relievers-do-not-use-in-infants-including-for-the-treatment-of-colic-gas-related-discomfort-or-constipation-dsi-2026-008/]]></link>
			<title>All rectal catheters (gas and colic relievers): Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008)</title>
			<pubDate><![CDATA[Tue, 18 Aug 2026 13:00:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-10-to-14-august-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-10-to-14-august-2026/]]></link>
			<title>Field Safety Notices: 10 to 14 August 2026</title>
			<pubDate><![CDATA[Tue, 18 Aug 2026 11:24:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-3-to-7-august-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-3-to-7-august-2026/]]></link>
			<title>Field Safety Notices: 3 to 7 August 2026</title>
			<pubDate><![CDATA[Tue, 11 Aug 2026 08:55:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-27-to-31-july-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-27-to-31-july-2026/]]></link>
			<title>Field Safety Notices: 27 to 31 July 2026</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 14:34:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/drager-atlan-anaesthesia-workstations-risk-of-ventilator-failure-dsi-2026-005/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/drager-atlan-anaesthesia-workstations-risk-of-ventilator-failure-dsi-2026-005/]]></link>
			<title>Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 13:00:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-july-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-july-2026/]]></link>
			<title>MHRA Safety Roundup: July 2026</title>
			<pubDate><![CDATA[Thu, 30 Jul 2026 13:03:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/belzer-uw-cold-storage-solution-and-belzer-mps-uw-machine-perfusion-solution-manufactured-by-carnamedica-ukrp-bridge-to-life-updated-advice-on-the-contamination-of-fluid-dsi-2026-00/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/belzer-uw-cold-storage-solution-and-belzer-mps-uw-machine-perfusion-solution-manufactured-by-carnamedica-ukrp-bridge-to-life-updated-advice-on-the-contamination-of-fluid-dsi-2026-00/]]></link>
			<title>Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)</title>
			<pubDate><![CDATA[Thu, 06 Aug 2026 12:59:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/devices-supplied-without-valid-ukca-ce-conformity-markings-or-certification-remove-from-use-and-place-in-quarantine-dsi-2026-007/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/devices-supplied-without-valid-ukca-ce-conformity-markings-or-certification-remove-from-use-and-place-in-quarantine-dsi-2026-007/]]></link>
			<title>Devices supplied without valid UKCA/CE conformity markings or certification: remove from use and place in quarantine  (DSI/2026/007)</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 13:00:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-6-to-10-july-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-6-to-10-july-2026/]]></link>
			<title>Field Safety Notices: 6 to 10 July 2026</title>
			<pubDate><![CDATA[Tue, 14 Jul 2026 09:19:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-neuraxpharm-uk-ltd-tuzulby-prolonged-release-chewable-tablets-el26a-36/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-neuraxpharm-uk-ltd-tuzulby-prolonged-release-chewable-tablets-el26a-36/]]></link>
			<title>Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 10:03:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/national-patient-safety-alert-resmed-astral-100-and-150-ventilators-potential-for-patient-harm-due-to-unexpected-interruption-of-ventilation-therapy-natpsa-2026-004-mhra/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/national-patient-safety-alert-resmed-astral-100-and-150-ventilators-potential-for-patient-harm-due-to-unexpected-interruption-of-ventilation-therapy-natpsa-2026-004-mhra/]]></link>
			<title>National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)</title>
			<pubDate><![CDATA[Mon, 17 Aug 2026 08:30:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-macarthys-laboratories-ltd-t-a-martindale-pharma-xaggitin-xl-prolonged-release-tablets-el26a-35/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-macarthys-laboratories-ltd-t-a-martindale-pharma-xaggitin-xl-prolonged-release-tablets-el26a-35/]]></link>
			<title>Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35</title>
			<pubDate><![CDATA[Mon, 20 Jul 2026 13:01:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-beckton-dickson-uk-ltd-chloraprep-1ml-applicator-el26a-34/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-beckton-dickson-uk-ltd-chloraprep-1ml-applicator-el26a-34/]]></link>
			<title>Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34</title>
			<pubDate><![CDATA[Mon, 13 Jul 2026 12:03:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-29-june-to-03-july-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-29-june-to-03-july-2026/]]></link>
			<title>Field Safety Notices: 29 June to 03 July 2026</title>
			<pubDate><![CDATA[Tue, 07 Jul 2026 11:14:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-22-to-26-june-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-22-to-26-june-2026/]]></link>
			<title>Field Safety Notices: 22 to 26 June 2026</title>
			<pubDate><![CDATA[Tue, 30 Jun 2026 15:02:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-june-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-june-2026/]]></link>
			<title>MHRA Safety Roundup: June 2026</title>
			<pubDate><![CDATA[Tue, 30 Jun 2026 13:09:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-3-medicines-recall-flamingo-pharma-uk-ltd-flucloxacillin-capsules-bp-500mg-el26a-32/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-3-medicines-recall-flamingo-pharma-uk-ltd-flucloxacillin-capsules-bp-500mg-el26a-32/]]></link>
			<title>Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32</title>
			<pubDate><![CDATA[Tue, 30 Jun 2026 11:58:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-relonchem-limited-gabapentin-relonchem-50mg-ml-oral-solution-el26a-31/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-relonchem-limited-gabapentin-relonchem-50mg-ml-oral-solution-el26a-31/]]></link>
			<title>Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31</title>
			<pubDate><![CDATA[Tue, 30 Jun 2026 10:06:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-24-to-28-august-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-24-to-28-august-2026/]]></link>
			<title>Field Safety Notices: 24 to 28 August 2026</title>
			<pubDate><![CDATA[Thu, 03 Sep 2026 14:45:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-brancaster-pharma-limited-benzylpenicillin-benzathine-1-2-million-i-u-and-2-4-million-i-u-powder-for-suspension-for-injection-el26a-30/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-brancaster-pharma-limited-benzylpenicillin-benzathine-1-2-million-i-u-and-2-4-million-i-u-powder-for-suspension-for-injection-el26a-30/]]></link>
			<title>Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30</title>
			<pubDate><![CDATA[Mon, 29 Jun 2026 10:00:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/allurion-gastric-balloon-updated-safety-information-due-to-the-risks-of-gastric-outlet-obstruction-small-bowel-obstruction-and-gastric-perforation-dsi-2026-004/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/allurion-gastric-balloon-updated-safety-information-due-to-the-risks-of-gastric-outlet-obstruction-small-bowel-obstruction-and-gastric-perforation-dsi-2026-004/]]></link>
			<title>Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)</title>
			<pubDate><![CDATA[Wed, 27 May 2026 13:21:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/token-of-trust-faq/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/token-of-trust-faq/]]></link>
			<title>Token of Trust FAQ</title>
			<pubDate><![CDATA[Fri, 26 Jun 2026 06:16:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-15-to-19-june-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-15-to-19-june-2026/]]></link>
			<title>Field Safety Notices: 15 to 19 June 2026</title>
			<pubDate><![CDATA[Tue, 23 Jun 2026 15:23:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-3-medicines-recall-orbit-pharma-limited-cyclizine-lactate-50-mg-ml-solution-for-injection-el26a-29/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-3-medicines-recall-orbit-pharma-limited-cyclizine-lactate-50-mg-ml-solution-for-injection-el26a-29/]]></link>
			<title>Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29</title>
			<pubDate><![CDATA[Tue, 16 Jun 2026 10:47:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-becton-dickinson-uk-ltd-chloraprep-2-1ml-and-chloraprep-frepp-2-1-5ml-applicators-el26a-26/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-becton-dickinson-uk-ltd-chloraprep-2-1ml-and-chloraprep-frepp-2-1-5ml-applicators-el26a-26/]]></link>
			<title>Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators, EL(26)A/26</title>
			<pubDate><![CDATA[Tue, 02 Jun 2026 13:04:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-25-to-29-may-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-25-to-29-may-2026/]]></link>
			<title>Field Safety Notices: 25 to 29 May 2026</title>
			<pubDate><![CDATA[Tue, 02 Jun 2026 10:52:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-bristol-laboratories-limited-phenoxymethylpenicillin-250-mg-5ml-sugar-free-oral-solution-bp-el26a-33/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-bristol-laboratories-limited-phenoxymethylpenicillin-250-mg-5ml-sugar-free-oral-solution-bp-el26a-33/]]></link>
			<title>Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33</title>
			<pubDate><![CDATA[Thu, 09 Jul 2026 10:07:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-teva-uk-ltd-ponlimsi-denosumab-60mg-solution-for-injection-in-pre-filled-syringe-el26a-27/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-teva-uk-ltd-ponlimsi-denosumab-60mg-solution-for-injection-in-pre-filled-syringe-el26a-27/]]></link>
			<title>Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27</title>
			<pubDate><![CDATA[Thu, 04 Jun 2026 10:00:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-8-12-june-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-8-12-june-2026/]]></link>
			<title>Field Safety Notices: 8 -12 June 2026</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 14:38:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-1-5-june-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-1-5-june-2026/]]></link>
			<title>Field Safety Notices: 1-5 June 2026</title>
			<pubDate><![CDATA[Mon, 08 Jun 2026 11:26:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-cadila-pharmaceuticals-limited-mirtazapine-30mg-tablets-el26a-28/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-4-medicines-defect-notification-cadila-pharmaceuticals-limited-mirtazapine-30mg-tablets-el26a-28/]]></link>
			<title>Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28</title>
			<pubDate><![CDATA[Mon, 08 Jun 2026 10:02:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/menb/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/menb/]]></link>
			<title>MenB Vaccine</title>
			<pubDate><![CDATA[Fri, 12 Jun 2026 16:39:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/travel-health/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/travel-health/]]></link>
			<title>Travel Health</title>
			<pubDate><![CDATA[Fri, 12 Jun 2026 10:40:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/product/nicotinamide-500mg-single-purchase/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/product/nicotinamide-500mg-single-purchase/]]></link>
			<title>Nicotinamide 500mg — Single Purchase</title>
			<pubDate><![CDATA[Fri, 05 Jun 2026 11:54:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-18-22-may-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-18-22-may-2026/]]></link>
			<title>Field Safety Notices: 18 -22 May 2026</title>
			<pubDate><![CDATA[Thu, 28 May 2026 15:24:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-crescent-pharma-limited-ramipril-2-5-mg-capsules-el26a-25/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/class-2-medicines-recall-crescent-pharma-limited-ramipril-2-5-mg-capsules-el26a-25/]]></link>
			<title>Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25</title>
			<pubDate><![CDATA[Thu, 28 May 2026 13:04:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-may-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/mhra-safety-roundup-may-2026/]]></link>
			<title>MHRA Safety Roundup: May 2026</title>
			<pubDate><![CDATA[Thu, 28 May 2026 12:07:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/risk-of-severe-harm-from-use-of-incorrect-giving-administration-set-for-blood-transfusion-dsi-2026-003/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/risk-of-severe-harm-from-use-of-incorrect-giving-administration-set-for-blood-transfusion-dsi-2026-003/]]></link>
			<title>Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)</title>
			<pubDate><![CDATA[Wed, 20 May 2026 13:01:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/vitamin-b12-injections/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/vitamin-b12-injections/]]></link>
			<title>Vitamin B12 Injections</title>
			<pubDate><![CDATA[Tue, 30 Jun 2026 20:07:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/kimal-procedure-packs-containing-recalled-components-namic-angiographic-syringe-with-the-risk-of-syringe-disconnection-namic-manifolds-with-the-risk-of-foreign-particulates-important-guidance-for-u/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/kimal-procedure-packs-containing-recalled-components-namic-angiographic-syringe-with-the-risk-of-syringe-disconnection-namic-manifolds-with-the-risk-of-foreign-particulates-important-guidance-for-u/]]></link>
			<title>Kimal Procedure Packs containing recalled components: Namic Angiographic Syringe with the risk of syringe disconnection; Namic Manifolds with the risk of foreign particulates. Important guidance for use in emergency situations (DSI/2026/002)</title>
			<pubDate><![CDATA[Tue, 19 May 2026 13:24:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/field-safety-notices-11-to-15-may-2026/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/field-safety-notices-11-to-15-may-2026/]]></link>
			<title>Field Safety Notices: 11 to 15 May 2026</title>
			<pubDate><![CDATA[Tue, 19 May 2026 11:50:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://kivetonpharmacy.com/]]></guid>
			<link><![CDATA[https://kivetonpharmacy.com/]]></link>
			<title>Home</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 16:35:23 +0000]]></pubDate>
		</item>
				</channel>
</rss>
